Table 1. Patient characteristics Patient... | American Society of Hematology

Table 1.

Patient characteristics

Patient	Stage at diagnosis		Stage at study		Prior treatment
Patient	Binet	Rai	Binet	Rai	Prior treatment
CLL1	A	I	A	0	CLB + pred
CLL2	C	IV	C	IV	CLB + pred; flu
CLL3	A	0	A	0	CLB
CLL4	A	I	A	I	CLB + pred
CLL5	A	I	A	I	CLB + pred
CLL6	C	IV	C	IV	CLB; CHOP; etoposide
CLL7	C	IV	C	IV	CLB; cyclo + pred
CLL8	A	I	A	I	None
CLL9	A	0	A	0	CLB; flu
CLL10	C	III	C	III	None
CLL11	A	0	A	0	None
CLL12	B	II	B	II	None
CLL13	A	0	A	0	None
CLL14	A	I	A	I	None
CLL15	C	III	C	III	None
CLL16	A	0	A	0	None
^*CLL17	B	II	C	IV	CLB; CHOP; flu
^*CLL18	A	I	B	II	CLB + flu
^†CLL19	A	I	A	I	None
^‡CLL20	B	II	B	II	pred; CLB + pred; cyclo + vincristine + pred
^‡CLL21	A	I	A	I	CLB + pred

Patient	Stage at diagnosis		Stage at study		Prior treatment
Patient	Binet	Rai	Binet	Rai	Prior treatment
CLL1	A	I	A	0	CLB + pred
CLL2	C	IV	C	IV	CLB + pred; flu
CLL3	A	0	A	0	CLB
CLL4	A	I	A	I	CLB + pred
CLL5	A	I	A	I	CLB + pred
CLL6	C	IV	C	IV	CLB; CHOP; etoposide
CLL7	C	IV	C	IV	CLB; cyclo + pred
CLL8	A	I	A	I	None
CLL9	A	0	A	0	CLB; flu
CLL10	C	III	C	III	None
CLL11	A	0	A	0	None
CLL12	B	II	B	II	None
CLL13	A	0	A	0	None
CLL14	A	I	A	I	None
CLL15	C	III	C	III	None
CLL16	A	0	A	0	None
^*CLL17	B	II	C	IV	CLB; CHOP; flu
^*CLL18	A	I	B	II	CLB + flu
^†CLL19	A	I	A	I	None
^‡CLL20	B	II	B	II	pred; CLB + pred; cyclo + vincristine + pred
^‡CLL21	A	I	A	I	CLB + pred

CLB indicates chlorambucil; CHOP, cyclophosphamide + doxorubicin + vincristine + predniolone; pred, prednisolone; flu, fludarabine; cyclo, cyclophosphamide.

Both PB cells and node were studied.

†

Only node examined.

‡

Only spleen examined.

View Large

This Feature Is Available To Subscribers Only